Ripertamab (Anti-CD20)
Ripertamab (Anti-CD20) is a chimeric monoclonal antibody directed against human CD20 with potential antineoplastic activity. MW : 144.56 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2805 |
| Sku # | A2805-1mg*25 |
| Pricing | 1mg*25, $5070.00 |